170 related articles for article (PubMed ID: 32128507)
1. Phthalate Exposures and MicroRNA Expression in Uterine Fibroids: The FORGE Study.
Zota AR; Geller RJ; VanNoy BN; Marfori CQ; Tabbara S; Hu LY; Baccarelli AA; Moawad GN
Epigenet Insights; 2020; 13():2516865720904057. PubMed ID: 32128507
[TBL] [Abstract][Full Text] [Related]
2. Phthalates exposure and uterine fibroid burden among women undergoing surgical treatment for fibroids: a preliminary study.
Zota AR; Geller RJ; Calafat AM; Marfori CQ; Baccarelli AA; Moawad GN
Fertil Steril; 2019 Jan; 111(1):112-121. PubMed ID: 30447935
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial Stress and MicroRNA Expression Profiles in Myometrial Tissue of Women Undergoing Surgical Treatment for Uterine Fibroids.
Dye CK; Wu H; VanNoy B; Calluori S; Marfori CQ; Baccarelli AA; Zota AR
Reprod Sci; 2024 Jun; 31(6):1651-1661. PubMed ID: 38379067
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial stress and microRNA expression profiles in myometrial tissue of women undergoing surgical treatment for uterine fibroids.
Dye CK; Wu H; VanNoy B; Calluori S; Marfori CQ; Baccarelli AA; Zota AR
Res Sq; 2023 Sep; ():. PubMed ID: 37790535
[TBL] [Abstract][Full Text] [Related]
5. Environmental estrogen-like endocrine disrupting chemicals and breast cancer.
Morgan M; Deoraj A; Felty Q; Roy D
Mol Cell Endocrinol; 2017 Dec; 457():89-102. PubMed ID: 27717745
[TBL] [Abstract][Full Text] [Related]
6. Midlife Urinary Phthalate Metabolite Concentrations and Prior Uterine Fibroid Diagnosis.
Pacyga DC; Ryva BA; Nowak RA; Bulun SE; Yin P; Li Z; Flaws JA; Strakovsky RS
Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270433
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
Karmon AE; Cardozo ER; Rueda BR; Styer AK
Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
[TBL] [Abstract][Full Text] [Related]
8. Parental contributions to early embryo development: influences of urinary phthalate and phthalate alternatives among couples undergoing IVF treatment.
Wu H; Ashcraft L; Whitcomb BW; Rahil T; Tougias E; Sites CK; Pilsner JR
Hum Reprod; 2017 Jan; 32(1):65-75. PubMed ID: 27927842
[TBL] [Abstract][Full Text] [Related]
9. The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis.
Bariani MV; Rangaswamy R; Siblini H; Yang Q; Al-Hendy A; Zota AR
Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):380-387. PubMed ID: 33044243
[TBL] [Abstract][Full Text] [Related]
10. Urinary concentrations of phthalate biomarkers and weight change among postmenopausal women: a prospective cohort study.
Díaz Santana MV; Hankinson SE; Bigelow C; Sturgeon SR; Zoeller RT; Tinker L; Manson JAE; Calafat AM; Meliker JR; Reeves KW
Environ Health; 2019 Mar; 18(1):20. PubMed ID: 30866962
[TBL] [Abstract][Full Text] [Related]
11. Unhealthy Levels of Phthalates and Bisphenol A in Mexican Pregnant Women with Gestational Diabetes and Its Association to Altered Expression of miRNAs Involved with Metabolic Disease.
Martínez-Ibarra A; Martínez-Razo LD; Vázquez-Martínez ER; Martínez-Cruz N; Flores-Ramírez R; García-Gómez E; López-López M; Ortega-González C; Camacho-Arroyo I; Cerbón M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284700
[TBL] [Abstract][Full Text] [Related]
12. Phthalate metabolites in obese individuals undergoing weight loss: Urinary levels and estimation of the phthalates daily intake.
Dirtu AC; Geens T; Dirinck E; Malarvannan G; Neels H; Van Gaal L; Jorens PG; Covaci A
Environ Int; 2013 Sep; 59():344-53. PubMed ID: 23892227
[TBL] [Abstract][Full Text] [Related]
13. Bisphenol A and phthalates in utero and in childhood: association with child BMI z-score and adiposity.
Yang TC; Peterson KE; Meeker JD; Sánchez BN; Zhang Z; Cantoral A; Solano M; Tellez-Rojo MM
Environ Res; 2017 Jul; 156():326-333. PubMed ID: 28390300
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic disparities in environmental endocrine disrupting chemicals and women's reproductive health outcomes: epidemiological examples across the life course.
James-Todd TM; Chiu YH; Zota AR
Curr Epidemiol Rep; 2016 Jun; 3(2):161-180. PubMed ID: 28497013
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
16. First-Trimester Urine Concentrations of Phthalate Metabolites and Phenols and Placenta miRNA Expression in a Cohort of U.S. Women.
LaRocca J; Binder AM; McElrath TF; Michels KB
Environ Health Perspect; 2016 Mar; 124(3):380-7. PubMed ID: 26090578
[TBL] [Abstract][Full Text] [Related]
17. Early microRNA indicators of PPARα pathway activation in the liver.
Chorley BN; Carswell GK; Nelson G; Bhat VS; Wood CE
Toxicol Rep; 2020; 7():805-815. PubMed ID: 32642447
[TBL] [Abstract][Full Text] [Related]
18. Racial disparity in maternal phthalates exposure; Association with racial disparity in fetal growth and birth outcomes.
Bloom MS; Wenzel AG; Brock JW; Kucklick JR; Wineland RJ; Cruze L; Unal ER; Yucel RM; Jiyessova A; Newman RB
Environ Int; 2019 Jun; 127():473-486. PubMed ID: 30981018
[TBL] [Abstract][Full Text] [Related]
19. Urinary concentrations of biomarkers of phthalates and phthalate alternatives and IVF outcomes.
Machtinger R; Gaskins AJ; Racowsky C; Mansur A; Adir M; Baccarelli AA; Calafat AM; Hauser R
Environ Int; 2018 Feb; 111():23-31. PubMed ID: 29161633
[TBL] [Abstract][Full Text] [Related]
20. Uterine fibroids and cardiovascular risk.
Uimari O; Auvinen J; Jokelainen J; Puukka K; Ruokonen A; Järvelin MR; Piltonen T; Keinänen-Kiukaanniemi S; Zondervan K; Järvelä I; Ryynänen M; Martikainen H
Hum Reprod; 2016 Dec; 31(12):2689-2703. PubMed ID: 27733532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
